Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Sales 87,010 83,040 86,190 87,990 86,310
Sales Growth +4.78% -3.65% -2.05% +1.95% +0.62%
Net Income -2,330 -500 4,520 -25,850 9,590
Net Income Growth -366.00% -111.06% +117.49% -369.55% +322.47%

Balance Sheet

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Total Assets 578,560 562,790 544,730 501,720 531,240
Total Assets Growth +2.80% +3.32% +8.57% -5.56% +3.24%
Total Liabilities 107,680 95,740 89,350 61,410 75,400
Total Liabilities Growth +12.47% +7.15% +45.50% -18.55% +2.57%

Cash Flow

(Values in U.S. Thousands) Dec, 2025 Sep, 2025 Jun, 2025 Mar, 2025 Dec, 2024
Operating Cash Flow 64,350 37,420 14,790 -6,040 64,870
Operating Cash Flow Growth +71.97% +153.01% +344.87% -109.31% +60.17%
Net Cash Flow -2,980 -34,150 -37,480 -30,020 20,870
Change in Net Cash Flow +91.27% +8.88% -24.85% -243.84% +637.89%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot